Last update: April 17, 2016

C26H41Br2NO4

Low Risk for breastfeeding


Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

A Calcium channel blocker with spasmolytic activity on the intestine and antimuscarinic effects.

At latest update no published data were found on excretion into breast milk.
Pharmacokinetic data (moderately high molecular weight and high protein binding) make unlikely the passage into milk in significant amounts.
Its low oral bioavailability hinders its passage into infant's plasma from ingested milk, except in preterm infants and immediate neonatal period, since they may exhibit an increased intestinal permeability.

Anticholinergics may reduce milk production: take a minimum necessary dose and avoid prolonged treatment if decreased milk is observed.

Alternatives

We do not have alternatives for C26H41Br2NO4.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

C26H41Br2NO4 is Pinaverium Bromide in Molecular formula.

Is written in other languages:

Tradenames

Main tradenames from several countries containing C26H41Br2NO4 in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 1 %
Molecular weight 591 daltons
Protein Binding 97 %
Tmax 1 hours
T1/2 1,5 hours

References

  1. BGP. Pinaverium. Product Monograph. 2015 Full text (in our servers)
  2. Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol. 2014 Abstract
  3. AEMPS. Pinaverio. Ficha técnica. 2014 Full text (in our servers)

Total visits

1,278

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by AELAMA

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM